|
|
||||||||
Drug Monitoring and Toxicology |
a Address correspondence to this author at: LDH-LNR, Ecole Nationale Vétérinaire (Ministère de l'Agriculture), BP 50707, 44307 Nantes Cedex 03 France. Fax (33)-2-40-68-77-45; e-mail ldhlnr{at}vet-nantes.fr.
The use of 4-chlorotestosterone acetate by farmers for cattle fattening
was recently demonstrated although the use of this anabolic steroid is
strictly forbidden in the European Union. We investigated the
metabolism of 4-chlorotestosterone acetate in the bovine species after
intramuscular and oral administration. Nineteen metabolites were
detected in urine after intramuscular injection, and eight metabolites
were identified. For this purpose, preparative HPLC, mass spectrometry
with different ionization modes (electronic impact and chemical
ionization), and different acquisition techniques were used (high
resolution, selected ion monitoring, and scan measurement). Metabolite
stereoisomerism was determined on the basis of retention time and
organic synthesis. 4-Chloroepitestosterone (M2),
4-chloroandrost-4-en-3
-ol-17-one (M3), and
4-chloroandrost-4-ene-3,17-dione (M4) were identified as the main
urinary markers of intramuscular administration. On the other hand,
4-chloroandrost-4-ene-3
,17ß-diol (M7),
4-chloroandrostan-3ß-ol-17-one (M5), and M2 were the primary
indicators of an oral administration. In addition, we have shown that
95% of the metabolites were sulfo-conjugated, except for M3, which was
partially conjugated to glucuronic acid. Finally, the main metabolites
(M2, M3, and M4) were easily identified for 1.5 months after
intramuscular administration.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |